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Objectives The purpose of this study was to assess the value of estimated glomerular filtration rate (eGFR) calculated by
different formulas for predicting the risk of death in heart failure (HF) outpatients.
Background Patients with both HF and renal insufficiency have a poor prognosis. Three formulas are mostly used to assess
renal function: Cockroft-Gault formula, MDRD-4 (Modification of Diet in Renal Disease Study) formula, and the
Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation. The prognostic values of these formulas
have not been adequately compared in HF patients.
Methods A total of 925 patients (72% men; age 69 years; interquartile range: 59 to 75.5 years) with a left ventricular
ejection fraction of 31% (interquartile range: 23.5% to 39%) were studied. Follow-up was 1,202 days (interquar-
tile range: 627.5 to 2,156.5 days). Measures of performance were evaluated using continuous data and by divid-
ing patients into 4 subgroups according to the eGFR: 90, 89 to 60, 60 to 30, and 30 ml/min/1.73 m2.
Results The 3 formulas correlated significantly, with the best correlation found between the MDRD-4 and CKD-EPI formu-
las. The 3 formulas afforded independent prognostic information over long-term follow-up. However, risk predic-
tion was most accurate using the Cockroft-Gault formula as evaluated by Cox proportional hazards models (haz-
ard ratio: 0.75 vs. 0.81 with the MDRD-4 formula and 0.80 with the CKD-EPI equation), area under the curve
(0.67 vs. 0.62 and 0.64, respectively), and Bayesian information criterion (both analyzing eGFR as a continuous
or categorical variable). Indeed, net reclassification improvement and integrated discrimination improvement
using the Cockroft-Gault formula were 21% and 5.04, respectively, versus the MDRD-4 formula (the most used)
and 13.1% and 3.77 respectively versus CKD-EPI equation (the more recent) (all p values 0.001).
Conclusions In this ambulatory, real-life cohort of HF patients, the Cockroft-Gault formula was the most accurate of the
3 used eGFR formulas to improve the risk stratification for death. (J Am Coll Cardiol 2012;59:1709–15)
© 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.11.066Renal insufficiency is prevalent in patients with heart failure
(HF), and the coexistence of both conditions results in a
worse prognosis (1–5). The most precise methods for
calculating kidney function, such as the isotopic glomerular
filtration rate (GFR) and creatinine clearance in a 24-h
urine specimen, are not used in daily clinical practice (6).
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2011, accepted November 29, 2011.Instead, several formulas based on creatinine clearance were
developed to calculate the estimated GFR (eGFR), the best
known of which are the Cockroft-Gault formula (7) and the
Modification of Diet in Renal Disease (MDRD) 6 formula
(8,9), as well as the simplified MDRD-4 formula (10). A
recent formula, the Chronic Kidney Disease Epidemiology
Collaboration (CKD-EPI) equation (11), has been de-
scribed and validated in population studies. The CKD-EPI
See page 1716
equation has been suggested to be more precise than the
MDRD formula (11). These formulas have been applied to
general populations and to patients with variable degrees of
renal insufficiency, although data on the application of these
mm
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pathological situations is scarce.
To the best of our knowledge,
the prognostic values of these
formulas have not been com-
pared in patients with HF. Our
objective was to assess the agree-
ment between the Cockroft-
Gault formula, the MDRD-4
formula, and the CKD-EPI
equation and evaluate their prog-
nostic role in a population of
outpatients with HF during
long-term follow-up.
Methods
Patients were consecutively re-
cruited from a multidisciplinary
HF unit integrated into a tertiary
hospital. Most patients were re-
ferred from cardiology (70%) and
internal medicine (15%), and the
principal referral criterion was
HF irrespective of etiology (at
least 1 HF hospitalization and/or
reduced left ventricular ejection
fraction [LVEF]). At the first
visit, patients gave us written con-
sent to obtain analytic samples and to use their clinical data for
research purposes. Follow-up visits included a minimum of a
visit every 3 months with a nurse and every 6 months with the
physician (cardiologist, internist, or family physician), and
optional visits with specialists in geriatrics, psychiatry, and
rehabilitation.
Of the 960 patients who were admitted to our HF unit
between August 2001 and December 2008, the eGFR at the
first follow-up visit and vital status at the end of follow-up were
available for 925 patients (96%) (in addition to other demo-
graphic, clinical, echocardiographic, and analytical data).
Three formulas were used: 1) the Cockroft-Gault formula,
(140  age in years)  weight in kg/(72  serum creatinine
level in mg/dl) adjusted by sex ( 0.85 in women) (7) and later
adjusted by body surface area; 2) the MDRD-4 formula,
186.3  creatinine1.154  age0.203  1.212 (if black) 
0.742 (if female) (10); and 3) the CKD-EPI equation, male:
141  minimum (creatinine/0.9, 1)0.411  maximum
(creatinine/0.9, 1)1.209  0.993Age  1.159 (if black);
female: 141  minimum (creatinine/0.7, 1)0.329  maxi-
um (creatinine/0.7, 1)1.209  0.993Age  1.018  1.159
(if black) (11).
Serum creatinine levels were analyzed using the CREA
method with a Dimension Clinical Chemistry System (Sie-
mens, Newark, New Jersey), using a modification of the kinetic
Jaffe reaction described by Larsen (8) with picrate as the
Abbreviations
and Acronyms
AUC  area under the
receiver-operating
characteristic curve
BIC  Bayesian information
criterion
CI  confidence interval
CKD-EPI  Chronic Kidney
Disease Epidemiology
Collaboration
eGFR  estimated
glomerular filtration rate
GFR  glomerular filtration
rate
HF  heart failure
ICC  intraclass
correlation coefficient
IDI  integrated
discrimination improvement
LoA  limits of agreement
LVEF  left ventricular
ejection fraction
MDRD  Modification of
Diet in Renal Disease
NRI  net reclassification
improvementreactant.The relationship between the eGFR and survival at the
end of follow-up was evaluated. Renal insufficiency was con-
sidered if the eGFR was 60 ml/min/1.73 m2. In addition, 4
subgroups of patients were analyzed according to the eGFR
following the stages defined in the clinical guidelines of the
National Kidney Foundation (6): 90 ml/min/1.73 m2; 89 to
60 ml/min/1.73 m2; 60 to 30 ml/min/1.73 m2; and 30
ml/min/1.73 m2. Patients from groups 4 (30 to 15
l/min/1.73 m2) and 5 (15 ml/min/1.73 m2 or on
dialysis) were merged into 1 group due to the small
number of patients in group 5.
Statistical analysis. Intraclass correlation coefficients
(ICCs) were used for correlations between pairs of contin-
uous variables, and Cohen’s kappa index was used for
categorical variables. Mean differences between scores and
95% limits of agreement (LoA) were analyzed using the
Bland-Altman method (12). To compare ICCs and kappa
values between pairing methods, we used bootstrap methods
with 500 replicates. Cox proportional hazard regression
models were used to model long-term survival as a function
of the formulas. Good prediction was determined by dis-
crimination and calibration (measures of performance). The
D’Agostino-Nam version of the Hosmer-Lemeshow
goodness-of-fit test was used to calculate a chi-square value
(calibration describes how closely the predicted probabilities
agree numerically with the actual outcomes) (13). A model
is well calibrated when predicted and observed values agree
for any reasonable grouping of the observation (no signifi-
cant differences in Hosmer-Lemeshow goodness-of-fit
test). The area under the receiver-operating characteristic
curve (AUC) summarized the diagnostic discrimination (dis-
crimination refers to a model’s ability to correctly distinguish
the 2 classes of outcomes). We used the index of rank
correlation, Somers’ D, which equals 2 (c 1/2), where c is
the concordance (discrimination) probability (14). This test
already incorporates information of censored data. The AUCs
between models were compared using the U-statistic test for
equality concordance. For each model, the Bayesian informa-
tion criterion (BIC) was calculated; given any 2 estimated
models, the model with the lower BIC value was preferred. No
statistical test can be performed between different BIC estima-
tions; the lower BIC is the better model. Reclassification
between the Cockroft-Gault formula, MDRD-4 formula, and
CKD-EPI equation from the Cox models were tested using
net reclassification improvement (NRI) and integrated dis-
crimination improvement (IDI), comparing quartiles of prob-
ability at 1,827 days. Analyses were performed with R, a
language and environment for statistical computing, version
2.11.1 (R Foundation for Statistical Computing, Vienna,
Austria).
Results
A total of 925 patients (72% men; median age 69 years;
interquartile range, 59 to 75.5 years) were studied (Table 1).
The etiology of HF was mainly ischemic heart disease
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23.5% to 39%). A total of 143 patients (15.5%) in this
cohort had LVEF45% and 224 patients (24%) had LVEF
40%. Most patients were in New York Heart Association
functional class II (55.6%) or III (36.3%). Median follow-up
was 1,202 days (interquartile range: 627.5 to 2,156.5 days).
The prevalence of renal insufficiency significantly differed
according to the different formulas: 58% with the Cockroft-
Patient Demographic andB s line Clinical Data and Treatments (N  925)Table 1 Patient Demographic a dBaseline Clinical Data and Treatments (N  925)
Age at first visit, yrs 69 (59–75.5)
Female 260 (28.1)
White 921 (99.6)
Etiology of HF
Ischemic heart disease 521 (56.3)
Idiopathic dilated cardiomyopathy 85 (9.2)
Hypertensive heart disease 84 (9.1)
Alcoholic cardiomyopathy 48 (5.2)
Toxic cardiomyopathy (drugs) 18 (1.9)
Valvular disease 97 (7.8)
Other 72 (7.8)
Time of HF (1st visit), months 12 (2–48)
Patients with HF admission in the previous year 595 (64.3)
Patients with HF admission in the past month 473 (51.1)
Left ventricular ejection fraction, % 31 (23.5–39.0)
Serum urea, mg/dl 57 (43–82)
Serum creatinine, mg/dl 1.2 (1.01–1.5)
Serum sodium, mmol/l 139 (137–141)
NT-proBNP (n  282), ng/l 1,786 (796–3,657)
Systolic arterial pressure, mm Hg 120 (110–140)
Heart rate, beats/min 72 (63–80.5)
Body mass index, kg/m2 27.1 (24.1–30.5)
NYHA functional class
I 55 (5.9)
II 514 (55.6)
III 336 (36.3)
IV 20 (2.2)
Comorbidities
Arterial hypertension 539 (58.3)
Diabetes mellitus 366 (39.6)
Hypercholesterolemia 405 (43.8)
Chronic obstructive pulmonary disease 193 (20.9)
Anemia (hemoglobin 12 g/dl) 303 (32.8)
Peripheral vascular disease 160 (17.3)
Treatments (study entry/follow-up)
ACEIs or ARBs 757/820 (78.9/88.6)
Beta-blockers 588/750 (61.3/81.1)
Spironolactone/eplerenone 238/343 (24.8/35.7)
Loop diuretics 731/770 (76.1/83.2)
Digoxin 261/279 (27.2/30.2)
Hydralazine 123/303 (12.8/32.8)
Nitrates 300/498 (32.4/53.8)
Statins 385/577 (40.1/62.4)
Antiplatelets 448/589 (48.4/63.7)
Values are median (interquartile range), n (%), or n/N (%/%).
ACEIs  angiotensin-converting enzyme inhibitors; ARBs  angiotensin II receptor blockers;
HF  heart failure; NT-proBNP  N-terminal pro–B-type natriuretic peptide; NYHA  New York
Heart Association.Gault formula, 49% with MDRD-4 formula, and 53% with cCKD-EPI equation (p  0.001 using the McNemar test).
he distribution of patients by National Kidney Foundation
roups according to the 3 formulas is shown in Table 2.
Agreement of measurements. Figure 1 shows the corre-
lation between formulas using scatterplot and Bland-
Altman analysis. The Cockroft-Gault and MDRD-4
formula values were quite similar when the eGFR was
low (60 ml/min/1.73 m2) (Fig. 1A, left). However, a
systematic difference was found, with Cockroft-Gault values
2.96 points (mean) lower than MDRD-4 values (95% LoA,
27.1 to 21.1) (Fig. 1A, right). When the eGFR was
high, differences between both formulas were very large, but
a specific tendency was not shown. The Cockroft-Gault and
CKD-EPI equation values were also quite similar when the
eGFR was low (Fig. 1B, left), with Cockroft-Gault formula
values 0.81 points (mean) lower than CKD-EPI equation
values (95% LoA, 21.8 to 20.2) (Fig. 1B, right). When
the Cockroft-Gault formula values were high, the CKD-
EPI equation values were systematically lower. The
MDRD-4 and CKD-EPI equation values were the most
similar among the different formulas, especially at a low
eGFR (Fig. 1C, left). MDRD-4 formula values were 2.16
points (95% LoA, 8.1 to 12.4) (Fig. 1C, right) lower
than CKD-EPI values. The ICCs for the 3 formulas are
shown in Table 3. Differences among the ICCs of the 3
pairings were all statistically significant as assessed by
bootstrap methods (all p 0.001).
When patients were classified into 4 subgroups (as
defined by the National Kidney Foundation) or only 2
subgroups (60 or 60 ml/min/1.73 m2), the best agree-
ent was found between the MDRD-4 and CKD-EPI
ormulas (kappa  0.856 and 0.905, respectively) and the
east between the Cockroft-Gault and MDRD-4 formulas
kappa  0.627 and 0.720, respectively) (Table 3). Using
he bootstrap method, differences in kappa values were
tatistically significant among all the combinations of the 3
ormulas for the 2 classifications (4 subgroups and 2
ubgroups) (all p values 0.001).
rediction, discrimination, and calibration. The 3 for-
ulas were effective for the prediction of long-term mor-
ality. However, the Cockroft-Gault formula was the most
ccurate, as evaluated by Cox proportional hazards models,
UC (Fig. 2, Table 4), and BIC (both analyzing the eGFR
s a continuous or categorical variable) (Table 4). All 3
ormulas performed correctly in terms of prognosis calibra-
ion, as shown by the Hosmer-Lemeshow goodness-of-fit
est (Table 4).
Long-term survival Kaplan-Meier curves using the 3
ormulas are shown in Figure 3. All of the formulas showed
highly significant predictive prognostic values (log-rank test,
p  0.001). However, the 4 eGFR groups diverged in a
ore pronounced way with the Cockroft-Gault formula:
hi-square values were 104.0 for Cockroft-Gault formula
ersus 70.0 for the CKD-EPI and 69.9 for MDRD-4
ormulas. Even after adjustment for other important HF
ovariates (age, sex, New York Heart Association functional
lass, LVEF, HF etiology, diabetes, plasma urea levels,
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blockers and angiotensin-converting enzyme inhibitors), the
Cockroft-Gault formula remained the most accurate for
predicting mortality.
Figure 1 Correlation and Agreement Between the 3 eGFR
Formulas
(A) Cockroft-Gault formula adjusted by body surface area and Modification of
Diet in Renal Disease (MDRD)-4 formula. (B) Cockroft-Gault formula adjusted
by body surface area and Chronic Kidney Disease Epidemiology Collaboration
(CKD-EPI) equation. (C) MDRD-4 formula and CKD-EPI equation. Scatterplot
(expected, correlation  1) (left). Bland-Altman analysis (right). x- and y-axis
values are in ml/min/1.73 m2. eGFR  estimated glomerular filtration rate.
Distribution of Patients by Renal Function According to the 3 FormTable 2 Distribution of Patients by Renal Function According t
Formula eGFR >90 ml/min/1.73 m2 eGFR 89–60 ml/min/
Cockroft-Gault 94 (10.2) 292 (31.6)
MDRD-4 92 (9.9) 383 (41.4)
CKD-EPI 87 (9.4) 344 (37.2)
Values are n (%).
CKD-EPI  Chronic Kidney Disease Epidemiology Collaboration; eGFR  estimated glomerularWe analyzed the performance of the 3 formulas for patients
with an LVEF 40% (n  224) and those with an LVEF
40% (n 701). Cockroft-Gault formula remained the most
ccurate formula for predicting survival in patients with a
reserved LVEF and in patients with a reduced LVEF.
Comparing clinical characteristics of patients of the
ifferent eGFR subgroups according to the classification
btained with each formula, Cockroft-Gault formula pa-
ients with an eGFR 90 ml/min/1.73 m2 were younger
(p  0.003) and had a higher body mass index (p  0.002).
n contrast, Cockroft-Gault formula patients with an eGFR
30 ml/min/1.73 m2 were older (p  0.004) and had lower
body weight (p  0.026) compared with MDRD and
KD-EPI formula patients, respectively. No differences in
he other clinical characteristics were found among the
ormulas.
Reclassification of patients according to quartiles of the
robability of dying at 1,827 days showed an NRI of 21.02%
95% confidence interval [CI]: 12.75 to 29.29; p  0.001)
when comparing the Cockroft-Gault formula with the
MDRD-4 formula and an NRI of 13.10% (95% CI: 5.6 to
20.6; p  0.001) when comparing the Cockroft-Gault
formula with the CKD-EPI equation. The comparison of
the MDRD-4 and CKD-EPI equations favored the CKD-
EPI equation (NRI of 8.58%; 95% CI: 4.27 to 12.89; p 
0.001). In sum, the Cockroft-Gault formula reclassified 1 of
5 patients better compared with the MDRD-4 formula and
1 of 8 patients compared with the CKD-EPI equation.
Reclassification using IDI also highly significantly favored
the Cockroft-Gault formula (IDI of 5.04 [95% CI: 4.1 to
5.97] vs. the MDRD-4 formula; p  0.001 and IDI: 3.77
[95% CI: 3.05 to 4.49] vs. the CKD-EPI equation; p 
0.001). On the other hand, the CKD-EPI equation did
better than the MDRD-4 formula (IDI of 1.27; 95% CI:
0.099 to 1.55; p  0.001).
Discussion
In this ambulatory, real-life cohort of HF patients, the
Cockroft-Gault formula performed better for predicting
death than the MDRD-4 formula or CKD-EPI equation.
The improvement in risk assessment remained strong when
it was estimated by means of statistical measures that
evaluate model prediction, discrimination, and calibration.
According to the National Kidney Foundation practice
guidelines (6), glomerular filtration is the best measurement
to assess renal function, although it depends on various
3 Formulas
2 eGFR <60–30 ml/min/1.73 m2 eGFR <30 ml/min/1.73 m2
433 (46.8) 106 (11.5)
372 (40.2) 78 (8.4)
398 (43.0) 96 (10.4)
n rate; MDRD  Modification of Diet in Renal Disease.ulaso the
1.73 mfactors, including age, sex, and body surface area. In daily
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glomerular filtration from serum creatinine, age, sex, race,
and weight. The Cockroft-Gault formula (7) was developed
in a population study and shown to determine more
precisely creatinine clearance in situations in which renal
function is only slightly altered. The formula tends to
overestimate glomerular filtration when the grade of renal
dysfunction is greater, partly because it was developed to
estimate creatinine clearance and not the GFR. However,
an abundance of literature compares the formula with other
measurements or estimations of the GFR. On the other
hand, the MDRD-6 and MDRD-4 formulas (8–10) were
studied in patients already diagnosed with renal insuffi-
ciency; as such, these formulas have less precision in patients
with slight alterations in kidney function. The predictive
values of both formulas for the estimation of the GFR were
previously compared in the general population. Froissart et
al. (15) observed that both formulas are much more precise
with lower filtration rates, and the MDRD-4 formula
appears to be more precise in the majority of categories
analyzed with respect to isotopic filtration. However, the
Cockroft-Gault formula seemed to fit better in studies of
mild alterations in renal function, and it appeared to be
better than the MDRD-4 formula in women 65 years of age
and older with an eGFR 60 ml/min/1.73 m2. Despite
Figure 2 AUC for eGFR Calculated With the 3 Formulas
AUC  area under the receiver-operating characteristic curve;
other abbreviations as in Figure 1.
Qualitative and Quantitative Correlations BetweTable 3 Qualitative and Quantitative Correla
Cockroft-Gault–MDRD-4
Kappa (95% CI)* 0.627 (0.585–0.669)
Kappa (95% CI)† 0.720 (0.675–0.765)
ICC (95% CI) 0.877 (0.852–0.897)
*Four categories: eGFR 90, 89–60, 60–30, and 30 ml/min/1.7
CI  confidence interval; ICC  intraclass correlation coefficient; otdthese differences, Froissart et al. concluded that both for-
mulas have little precision and may inappropriately classify
approximately 30% of the population. In 2009, Levey et al.
(11) reported a new way to calculate glomerular filtration,
the CKD-EPI equation, which they developed in a popu-
lation of 16,000 participants. In addition to validating the
formula, which takes into account serum creatinine, age,
sex, and race, the study compared the formula with a variant
of the MDRD formula (8) and found it to be more precise
for classifying individuals with an eGFR 60 ml/min/1.73
m2, but it still remained suboptimal. In our study of patients
with HF, the best correlation among the formulas was
between the MDRD-4 and CKD-EPI formulas. As with all
formulas based on serum creatinine, these formulas are
subject to the same bias as creatinine values, especially in
overweight and underweight patients in whom muscle mass
can influence the serum creatinine level. Small studies have
been published in the past that compare the different
methods of calculating the eGFR. Eastwood et al. (16)
compared creatinine clearance in 24-h urine and the eGFR
using the MDRD-4, CKD-EPI, and Cockroft-Gault for-
mulas in a population of individuals from sub-Saharan
Africa between the ages of 40 and 75 years who had low
body mass index values and weight and a mean filtration
rate of 84 ml/min/1.73 m2. The filtration rate that was most
imilar to the rate calculated with the 24-h urine specimen
as that calculated with the CKD-EPI equation, although
urprisingly only when it was used without adjusting for the
lack race. The CKD-EPI equation and MDRD-4 formula
ere also compared in a study of Australian adults (17) in
hich the CKD-EPI equation determined a lower preva-
ence of renal insufficiency than the MDRD-4 formula. In
ontrast, the lower prevalence of renal insufficiency in our
tudy was determined using the MDRD-4 formula.
Interest in analyzing the association between renal insuf-
ciency and HF has grown over the past few years; as such,
ifferent methods and formulas to estimate renal function in
hese patients have been described. However, the eGFR
ormulas have not been exhaustively evaluated in patients
ith important comorbidities, such as HF itself. O’Meara et
l. (18) analyzed 45 patients with advanced HF who were
ndergoing a pre-transplantation assessment and concluded
hat the MDRD formula, especially MDRD-1, is the most
dequate for predicting renal function in these patients,
nding it to have better precision than the Cockroft-Gault
ormula with respect to isotopic filtration. Subsequently,
milde et al. (19) not only compared the precision of the
ethodsBetween Methods
Cockroft-Gault–CKD-EPI MDRD-4–CKD-EPI
0.725 (0.687–0.762) 0.856 (0.831–0.888)
0.803 (0.764–0.842) 0.905 (0.878–0.932)
0.909 (0.897–0.920) 0.972 (0.956–0.981)
Two categories: eGFR 60 or 60 ml/min/1.73 m2.
reviations as in Table 2.en Mtions
2ifferent formulas for estimating renal function in 110
vs. CKD
rion; HR
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tion, but they were also the first investigators to analyze the
prognostic values of the MDRD-6, MDRD-4, and
Cockroft-Gault formulas with respect to isotopic filtration.
In this study, the investigators concluded that the
MDRD-6 formula was more accurate, despite a greater
deviation, although all of the formulas tended to overesti-
mate lower filtration rates and underestimate more elevated
filtration rates, a finding that had also been reported in a
healthy population.
In our study, the 3 eGFR formulas were shown to be
valuable prognostic predictors, but the Cockroft-Gault for-
mula had significantly better results. However, we did not
compare the efficacy of the 3 eGFR formulas with respect to
the actual filtration rate, as done in previous studies. Our
objective was to assess the prognostic values of the mostly
used formulas in clinical practice in HF patients. Smilde et
al. (19) also looked at the prognostic value of isotopic
filtration, which was the best predictor, as well as the value
of the other formulas, finding MDRD and the simplified
MDRD to have better predictive abilities and the Cockroft-
Figure 3 Long-Term Kaplan-Meier Survival Curves
(A) Cockroft-Gault formula adjusted by body surface area. (B) MDRD-4 formula. (C
HR, AUC, Hosmer-Lemeshow Goodness-of-Fit Test, and BIC for DiffeTable 4 HR, AUC, Hosmer-Lemeshow Goodness-of-Fit Test, and
Long-Term Survival Cockroft-Gault MDRD-4
HR (95% CI)† 0.75 (0.71–0.79) 0.81 (0.77–0.85)
AUC 0.67 (0.64–0.70) 0.62 (0.59–0.65)
HL, chi-square (p value) 7.4 (0.491) 5.5 (0.705)
BIC (eGFR continuous) 4,358 4,418
BIC (eGFR categorical) 4,375 4,415
*p value 1: Cockroft-Gault vs. MDRD-4; p value 2: Cockroft-Gault vs. CKD-EPI; p value 3: MDRD-4
AUC  area under the receiver-operating characteristic curve; BIC  Bayesian information criteGault formula to have the worst predictive prognosis among
the analyzed formulas. They looked at a composite end point
of death, heart transplantation, myocardial infarction, primary
percutaneous transluminal coronary angioplasty, or an admis-
sion because HF within 12 months, comparing their AUCs. In
contrast, our larger study population (925 patients vs. 110
patients) and longer follow-up found the Cockroft-Gault
formula to be the best prognostic predictor of mortality on
long-term follow-up. The comparison made in our study is
more comprehensive, incorporating new reclassification crite-
ria. The Cockroft-Gault formula has demonstrated better
prognostication because of the greatest value of AUC, the
lowest BIC, the absence of statistical significance on the
Hosmer-Lemeshow goodness-of-fit test, and the better results
in the 2 reclassification tests used. Remarkably, the Cockroft-
Gault formula better classified 1 of 5 patients compared with
the MDRD-4 formula and 1 of 8 patients compared with the
CKD-EPI equation. We do not have a clear explanation for
the observed differences in the prognostic ability of the
Cockroft-Gault formula. A possible explanation for the better
predictive value of the Cockroft-Gault formula over the
-EPI equation. Abbreviations as in Figure 1.
Methods Using Cox Modelsfor Different Methods Using Cox Models
CKD-EPI p Value 1* p Value 2* p Value 3*
0.80 (0.76–0.84) 0.03 0.10 0.59
0.64 (0.60–0.67) 0.001 0.001 0.001
5.6 (0.692)
4,404
4,413
-EPI. †For each 10-point increase in the scale.
 hazard ratio; other abbreviations as in Tables 2 and 3.) CKDrentBIC
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May 8, 2012:1709–15 eGFR Formulas and Prognosis in Heart FailureMDRD-4 and CKD-EPI formulas is that the patient’s weight
is included in the formula. This fact may be key because body
mass index is known to be significantly associated with survival
in HF patients (20).
The better predictive value of the Cockroft-Gault for-
mula over the MDRD-4 formula was also observed in a
short follow-up (1 year) study after acute myocardial infarc-
tion (21). Similar to our results, the investigators found that
the Cockroft-Gault formula tends to calculate a lower
eGFR than the MDRD-4 formula in the elderly and those
with low body weight and a higher eGFR in young patients
and those with high body weight. The investigators con-
cluded that this fact largely explains why the Cockroft-
Gault formula is better for predicting mortality. As in our
case, the investigators found that the Cockroft-Gault for-
mula classified a greater number of patients as having
moderate and severe renal dysfunction than the MDRD-4
formula. This may partly be explained by HF patients being
older, having impaired hemodynamics and renal perfusion,
and being treated with angiotensin-converting enzyme in-
hibitors, angiotensin II receptor blockers, and other drugs
that may influence eGFR estimation using these formulas.
Study limitations. The study only compares the 3 formu-
as, and no gold standard study of GFR, such as an isotopic
easurement, has been performed. We did not have data
or the cystatin C levels of our patients or microalbuminuria.
e cannot disregard the fact that, in a small number of
atients, the reference weight during the first visit that was
sed for the Cockroft-Gault formula may not have been the
rue dry weight and could have been overestimated. Our
opulation was a general HF population treated at a specific
nd multidisciplinary HF unit in a tertiary hospital, and
ost patients were referred from the cardiology department,
esulting in relatively young men with HF of ischemic
tiology and reduced LVEF. As such, the results that we
btained cannot necessarily be extrapolated to a global HF
opulation. In addition, the almost exclusively white popu-
ation limits the generalization of the findings.
onclusions
f the 3 eGFR formulas used, the Cockroft-Gault formula
as the most accurate for predicting death in ambulatory
atients with HF.
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